Loading…
Transrectal versus transperineal prostate fusion biopsy: a pair-matched analysis to evaluate accuracy and complications
Purpose To evaluate biopsy-related complications and detection rates of any PCa and clinically significant PCa (csPCa, intended as grade group ≥ 2) between MRI-targeted TP fusion biopsies (TPBx) and TR ones (TRBx). Methods We performed a multicentric study on 4841 patients who underwent fusion biops...
Saved in:
| Published in: | World journal of urology 2024-09, Vol.42 (1), p.535, Article 535 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | |
|---|---|
| cites | cdi_FETCH-LOGICAL-c356t-3e9e98c0dd413d89663b69fb061bb6c7a21f09dbe9acd975e5f185f4cf410ac53 |
| container_end_page | |
| container_issue | 1 |
| container_start_page | 535 |
| container_title | World journal of urology |
| container_volume | 42 |
| creator | Oderda, Marco Diamand, Romain Abou Zahr, Rawad Anract, Julien Assenmacher, Gregoire Barry Delongchamps, Nicolas Bui, Alexandre Patrick Benamran, Daniel Calleris, Giorgio Dariane, Charles Ferriero, Mariaconsiglia Fiard, Gaelle Taha, Fayek Fourcade, Alexandre Fournier, Georges Guenzel, Karsten Halinski, Adam Marra, Giancarlo Ploussard, Guillaume Rysankova, Katerina Roche, Jean-Baptiste Simone, Giuseppe Windisch, Olivier Gontero, Paolo |
| description | Purpose
To evaluate biopsy-related complications and detection rates of any PCa and clinically significant PCa (csPCa, intended as grade group ≥ 2) between MRI-targeted TP fusion biopsies (TPBx) and TR ones (TRBx).
Methods
We performed a multicentric study on 4841 patients who underwent fusion biopsy between 2016 and 2023. A case–control matching was performed to find comparable cohorts of 646 TPBx and 646 TRBx. Mean T test and Pearson chi-square tests were used to compare continuous and categorical variables.
Results
Baseline characteristics were comparable between the cohorts, except for target location with a higher rate of anterior lesions in TPBx group. Complications were rare and no difference was found between the groups, with similar rates of infections after TRBx and TPBx (N = 5 (0.8%) vs N = 2 (0.3%), p 0.45). All patients in TRBx and 90.1% in TPBx group received antibiotic prophylaxis. A higher csPCa detection rate was found in TPBx over the group (50.5% vs 36.2%, p |
| doi_str_mv | 10.1007/s00345-024-05245-1 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11424653</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3109430157</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-3e9e98c0dd413d89663b69fb061bb6c7a21f09dbe9acd975e5f185f4cf410ac53</originalsourceid><addsrcrecordid>eNp9kUtv1TAQhS0EoqXwB1ggS2zYBDzxI9dsEKp4SZXYlLU1cSatqyQOdnLR_ff4klIKC1Yeeb5z7JnD2HMQr0GI5k0WQipdiVpVQtelggfsFJSU1a6pzcN79Ql7kvONENAYoR-zE2llXSRwyn5cJpxyIr_gwPeU8pr5cryaKYWJyuWcYl5wId6vOcSJtyHO-fCWI58xpGrExV9Tx3HC4ZBDUUdOexzWowS9XxP6Q-l23MdxHoLHpbjkp-xRj0OmZ7fnGfv28cPl-efq4uunL-fvLyovtVkqSZbszouuUyC7nTVGtsb2rTDQtsY3WEMvbNeSRd_ZRpPuYad75XsFAr2WZ-zd5juv7Uidp6lMN7g5hRHTwUUM7u_OFK7dVdw7AFUro2VxeHXrkOL3lfLixpA9DQNOFNfsJAirpADdFPTlP-hNXFNZzEbp2hgQhao3ypfNltX3d78B4Y7Bui1YV4J1v4J1UEQv7s9xJ_mdZAHkBuTSmq4o_Xn7P7Y_Ae67sfE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3109526610</pqid></control><display><type>article</type><title>Transrectal versus transperineal prostate fusion biopsy: a pair-matched analysis to evaluate accuracy and complications</title><source>Springer Nature</source><creator>Oderda, Marco ; Diamand, Romain ; Abou Zahr, Rawad ; Anract, Julien ; Assenmacher, Gregoire ; Barry Delongchamps, Nicolas ; Bui, Alexandre Patrick ; Benamran, Daniel ; Calleris, Giorgio ; Dariane, Charles ; Ferriero, Mariaconsiglia ; Fiard, Gaelle ; Taha, Fayek ; Fourcade, Alexandre ; Fournier, Georges ; Guenzel, Karsten ; Halinski, Adam ; Marra, Giancarlo ; Ploussard, Guillaume ; Rysankova, Katerina ; Roche, Jean-Baptiste ; Simone, Giuseppe ; Windisch, Olivier ; Gontero, Paolo</creator><creatorcontrib>Oderda, Marco ; Diamand, Romain ; Abou Zahr, Rawad ; Anract, Julien ; Assenmacher, Gregoire ; Barry Delongchamps, Nicolas ; Bui, Alexandre Patrick ; Benamran, Daniel ; Calleris, Giorgio ; Dariane, Charles ; Ferriero, Mariaconsiglia ; Fiard, Gaelle ; Taha, Fayek ; Fourcade, Alexandre ; Fournier, Georges ; Guenzel, Karsten ; Halinski, Adam ; Marra, Giancarlo ; Ploussard, Guillaume ; Rysankova, Katerina ; Roche, Jean-Baptiste ; Simone, Giuseppe ; Windisch, Olivier ; Gontero, Paolo</creatorcontrib><description>Purpose
To evaluate biopsy-related complications and detection rates of any PCa and clinically significant PCa (csPCa, intended as grade group ≥ 2) between MRI-targeted TP fusion biopsies (TPBx) and TR ones (TRBx).
Methods
We performed a multicentric study on 4841 patients who underwent fusion biopsy between 2016 and 2023. A case–control matching was performed to find comparable cohorts of 646 TPBx and 646 TRBx. Mean T test and Pearson chi-square tests were used to compare continuous and categorical variables.
Results
Baseline characteristics were comparable between the cohorts, except for target location with a higher rate of anterior lesions in TPBx group. Complications were rare and no difference was found between the groups, with similar rates of infections after TRBx and TPBx (N = 5 (0.8%) vs N = 2 (0.3%), p 0.45). All patients in TRBx and 90.1% in TPBx group received antibiotic prophylaxis. A higher csPCa detection rate was found in TPBx over the group (50.5% vs 36.2%, p < 0.001). On average, positive targeted cores were increased in TPBx group, for any PCa (1.6 vs 1.4, p 0.04) and csPCa (1.0 vs 0.8, p 0.02). Among the limitations of study, we acknowledge the retrospective design and the possible under-reporting of complications.
Conclusions
MRI-targeted fusion TPBx achieves a significantly higher csPCa detection than TRBx, with a diagnostic advantage for apical and anterior lesions. No significant differences were found in terms of complications that were rare in both groups, considering a widespread adoption of antibiotic prophylaxis.</description><identifier>ISSN: 1433-8726</identifier><identifier>ISSN: 0724-4983</identifier><identifier>EISSN: 1433-8726</identifier><identifier>DOI: 10.1007/s00345-024-05245-1</identifier><identifier>PMID: 39320521</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Aged ; Antibiotics ; Biopsy ; Case-Control Studies ; Disease prevention ; Humans ; Image-Guided Biopsy - adverse effects ; Image-Guided Biopsy - methods ; Magnetic Resonance Imaging ; Male ; Matched-Pair Analysis ; Medicine ; Medicine & Public Health ; Middle Aged ; Nephrology ; Oncology ; Perineum ; Postoperative Complications - epidemiology ; Prophylaxis ; Prostate - pathology ; Prostatic Neoplasms - pathology ; Rectum ; Reproducibility of Results ; Retrospective Studies ; Urology</subject><ispartof>World journal of urology, 2024-09, Vol.42 (1), p.535, Article 535</ispartof><rights>The Author(s) 2024</rights><rights>2024. The Author(s).</rights><rights>Copyright Springer Nature B.V. Dec 2024</rights><rights>The Author(s) 2024 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c356t-3e9e98c0dd413d89663b69fb061bb6c7a21f09dbe9acd975e5f185f4cf410ac53</cites><orcidid>0000-0003-4681-888X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,777,781,882,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39320521$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Oderda, Marco</creatorcontrib><creatorcontrib>Diamand, Romain</creatorcontrib><creatorcontrib>Abou Zahr, Rawad</creatorcontrib><creatorcontrib>Anract, Julien</creatorcontrib><creatorcontrib>Assenmacher, Gregoire</creatorcontrib><creatorcontrib>Barry Delongchamps, Nicolas</creatorcontrib><creatorcontrib>Bui, Alexandre Patrick</creatorcontrib><creatorcontrib>Benamran, Daniel</creatorcontrib><creatorcontrib>Calleris, Giorgio</creatorcontrib><creatorcontrib>Dariane, Charles</creatorcontrib><creatorcontrib>Ferriero, Mariaconsiglia</creatorcontrib><creatorcontrib>Fiard, Gaelle</creatorcontrib><creatorcontrib>Taha, Fayek</creatorcontrib><creatorcontrib>Fourcade, Alexandre</creatorcontrib><creatorcontrib>Fournier, Georges</creatorcontrib><creatorcontrib>Guenzel, Karsten</creatorcontrib><creatorcontrib>Halinski, Adam</creatorcontrib><creatorcontrib>Marra, Giancarlo</creatorcontrib><creatorcontrib>Ploussard, Guillaume</creatorcontrib><creatorcontrib>Rysankova, Katerina</creatorcontrib><creatorcontrib>Roche, Jean-Baptiste</creatorcontrib><creatorcontrib>Simone, Giuseppe</creatorcontrib><creatorcontrib>Windisch, Olivier</creatorcontrib><creatorcontrib>Gontero, Paolo</creatorcontrib><title>Transrectal versus transperineal prostate fusion biopsy: a pair-matched analysis to evaluate accuracy and complications</title><title>World journal of urology</title><addtitle>World J Urol</addtitle><addtitle>World J Urol</addtitle><description>Purpose
To evaluate biopsy-related complications and detection rates of any PCa and clinically significant PCa (csPCa, intended as grade group ≥ 2) between MRI-targeted TP fusion biopsies (TPBx) and TR ones (TRBx).
Methods
We performed a multicentric study on 4841 patients who underwent fusion biopsy between 2016 and 2023. A case–control matching was performed to find comparable cohorts of 646 TPBx and 646 TRBx. Mean T test and Pearson chi-square tests were used to compare continuous and categorical variables.
Results
Baseline characteristics were comparable between the cohorts, except for target location with a higher rate of anterior lesions in TPBx group. Complications were rare and no difference was found between the groups, with similar rates of infections after TRBx and TPBx (N = 5 (0.8%) vs N = 2 (0.3%), p 0.45). All patients in TRBx and 90.1% in TPBx group received antibiotic prophylaxis. A higher csPCa detection rate was found in TPBx over the group (50.5% vs 36.2%, p < 0.001). On average, positive targeted cores were increased in TPBx group, for any PCa (1.6 vs 1.4, p 0.04) and csPCa (1.0 vs 0.8, p 0.02). Among the limitations of study, we acknowledge the retrospective design and the possible under-reporting of complications.
Conclusions
MRI-targeted fusion TPBx achieves a significantly higher csPCa detection than TRBx, with a diagnostic advantage for apical and anterior lesions. No significant differences were found in terms of complications that were rare in both groups, considering a widespread adoption of antibiotic prophylaxis.</description><subject>Aged</subject><subject>Antibiotics</subject><subject>Biopsy</subject><subject>Case-Control Studies</subject><subject>Disease prevention</subject><subject>Humans</subject><subject>Image-Guided Biopsy - adverse effects</subject><subject>Image-Guided Biopsy - methods</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Matched-Pair Analysis</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Nephrology</subject><subject>Oncology</subject><subject>Perineum</subject><subject>Postoperative Complications - epidemiology</subject><subject>Prophylaxis</subject><subject>Prostate - pathology</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Rectum</subject><subject>Reproducibility of Results</subject><subject>Retrospective Studies</subject><subject>Urology</subject><issn>1433-8726</issn><issn>0724-4983</issn><issn>1433-8726</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kUtv1TAQhS0EoqXwB1ggS2zYBDzxI9dsEKp4SZXYlLU1cSatqyQOdnLR_ff4klIKC1Yeeb5z7JnD2HMQr0GI5k0WQipdiVpVQtelggfsFJSU1a6pzcN79Ql7kvONENAYoR-zE2llXSRwyn5cJpxyIr_gwPeU8pr5cryaKYWJyuWcYl5wId6vOcSJtyHO-fCWI58xpGrExV9Tx3HC4ZBDUUdOexzWowS9XxP6Q-l23MdxHoLHpbjkp-xRj0OmZ7fnGfv28cPl-efq4uunL-fvLyovtVkqSZbszouuUyC7nTVGtsb2rTDQtsY3WEMvbNeSRd_ZRpPuYad75XsFAr2WZ-zd5juv7Uidp6lMN7g5hRHTwUUM7u_OFK7dVdw7AFUro2VxeHXrkOL3lfLixpA9DQNOFNfsJAirpADdFPTlP-hNXFNZzEbp2hgQhao3ypfNltX3d78B4Y7Bui1YV4J1v4J1UEQv7s9xJ_mdZAHkBuTSmq4o_Xn7P7Y_Ae67sfE</recordid><startdate>20240925</startdate><enddate>20240925</enddate><creator>Oderda, Marco</creator><creator>Diamand, Romain</creator><creator>Abou Zahr, Rawad</creator><creator>Anract, Julien</creator><creator>Assenmacher, Gregoire</creator><creator>Barry Delongchamps, Nicolas</creator><creator>Bui, Alexandre Patrick</creator><creator>Benamran, Daniel</creator><creator>Calleris, Giorgio</creator><creator>Dariane, Charles</creator><creator>Ferriero, Mariaconsiglia</creator><creator>Fiard, Gaelle</creator><creator>Taha, Fayek</creator><creator>Fourcade, Alexandre</creator><creator>Fournier, Georges</creator><creator>Guenzel, Karsten</creator><creator>Halinski, Adam</creator><creator>Marra, Giancarlo</creator><creator>Ploussard, Guillaume</creator><creator>Rysankova, Katerina</creator><creator>Roche, Jean-Baptiste</creator><creator>Simone, Giuseppe</creator><creator>Windisch, Olivier</creator><creator>Gontero, Paolo</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4681-888X</orcidid></search><sort><creationdate>20240925</creationdate><title>Transrectal versus transperineal prostate fusion biopsy: a pair-matched analysis to evaluate accuracy and complications</title><author>Oderda, Marco ; Diamand, Romain ; Abou Zahr, Rawad ; Anract, Julien ; Assenmacher, Gregoire ; Barry Delongchamps, Nicolas ; Bui, Alexandre Patrick ; Benamran, Daniel ; Calleris, Giorgio ; Dariane, Charles ; Ferriero, Mariaconsiglia ; Fiard, Gaelle ; Taha, Fayek ; Fourcade, Alexandre ; Fournier, Georges ; Guenzel, Karsten ; Halinski, Adam ; Marra, Giancarlo ; Ploussard, Guillaume ; Rysankova, Katerina ; Roche, Jean-Baptiste ; Simone, Giuseppe ; Windisch, Olivier ; Gontero, Paolo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-3e9e98c0dd413d89663b69fb061bb6c7a21f09dbe9acd975e5f185f4cf410ac53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Aged</topic><topic>Antibiotics</topic><topic>Biopsy</topic><topic>Case-Control Studies</topic><topic>Disease prevention</topic><topic>Humans</topic><topic>Image-Guided Biopsy - adverse effects</topic><topic>Image-Guided Biopsy - methods</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Matched-Pair Analysis</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Nephrology</topic><topic>Oncology</topic><topic>Perineum</topic><topic>Postoperative Complications - epidemiology</topic><topic>Prophylaxis</topic><topic>Prostate - pathology</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Rectum</topic><topic>Reproducibility of Results</topic><topic>Retrospective Studies</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oderda, Marco</creatorcontrib><creatorcontrib>Diamand, Romain</creatorcontrib><creatorcontrib>Abou Zahr, Rawad</creatorcontrib><creatorcontrib>Anract, Julien</creatorcontrib><creatorcontrib>Assenmacher, Gregoire</creatorcontrib><creatorcontrib>Barry Delongchamps, Nicolas</creatorcontrib><creatorcontrib>Bui, Alexandre Patrick</creatorcontrib><creatorcontrib>Benamran, Daniel</creatorcontrib><creatorcontrib>Calleris, Giorgio</creatorcontrib><creatorcontrib>Dariane, Charles</creatorcontrib><creatorcontrib>Ferriero, Mariaconsiglia</creatorcontrib><creatorcontrib>Fiard, Gaelle</creatorcontrib><creatorcontrib>Taha, Fayek</creatorcontrib><creatorcontrib>Fourcade, Alexandre</creatorcontrib><creatorcontrib>Fournier, Georges</creatorcontrib><creatorcontrib>Guenzel, Karsten</creatorcontrib><creatorcontrib>Halinski, Adam</creatorcontrib><creatorcontrib>Marra, Giancarlo</creatorcontrib><creatorcontrib>Ploussard, Guillaume</creatorcontrib><creatorcontrib>Rysankova, Katerina</creatorcontrib><creatorcontrib>Roche, Jean-Baptiste</creatorcontrib><creatorcontrib>Simone, Giuseppe</creatorcontrib><creatorcontrib>Windisch, Olivier</creatorcontrib><creatorcontrib>Gontero, Paolo</creatorcontrib><collection>SpringerOpen (Open Access)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oderda, Marco</au><au>Diamand, Romain</au><au>Abou Zahr, Rawad</au><au>Anract, Julien</au><au>Assenmacher, Gregoire</au><au>Barry Delongchamps, Nicolas</au><au>Bui, Alexandre Patrick</au><au>Benamran, Daniel</au><au>Calleris, Giorgio</au><au>Dariane, Charles</au><au>Ferriero, Mariaconsiglia</au><au>Fiard, Gaelle</au><au>Taha, Fayek</au><au>Fourcade, Alexandre</au><au>Fournier, Georges</au><au>Guenzel, Karsten</au><au>Halinski, Adam</au><au>Marra, Giancarlo</au><au>Ploussard, Guillaume</au><au>Rysankova, Katerina</au><au>Roche, Jean-Baptiste</au><au>Simone, Giuseppe</au><au>Windisch, Olivier</au><au>Gontero, Paolo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transrectal versus transperineal prostate fusion biopsy: a pair-matched analysis to evaluate accuracy and complications</atitle><jtitle>World journal of urology</jtitle><stitle>World J Urol</stitle><addtitle>World J Urol</addtitle><date>2024-09-25</date><risdate>2024</risdate><volume>42</volume><issue>1</issue><spage>535</spage><pages>535-</pages><artnum>535</artnum><issn>1433-8726</issn><issn>0724-4983</issn><eissn>1433-8726</eissn><abstract>Purpose
To evaluate biopsy-related complications and detection rates of any PCa and clinically significant PCa (csPCa, intended as grade group ≥ 2) between MRI-targeted TP fusion biopsies (TPBx) and TR ones (TRBx).
Methods
We performed a multicentric study on 4841 patients who underwent fusion biopsy between 2016 and 2023. A case–control matching was performed to find comparable cohorts of 646 TPBx and 646 TRBx. Mean T test and Pearson chi-square tests were used to compare continuous and categorical variables.
Results
Baseline characteristics were comparable between the cohorts, except for target location with a higher rate of anterior lesions in TPBx group. Complications were rare and no difference was found between the groups, with similar rates of infections after TRBx and TPBx (N = 5 (0.8%) vs N = 2 (0.3%), p 0.45). All patients in TRBx and 90.1% in TPBx group received antibiotic prophylaxis. A higher csPCa detection rate was found in TPBx over the group (50.5% vs 36.2%, p < 0.001). On average, positive targeted cores were increased in TPBx group, for any PCa (1.6 vs 1.4, p 0.04) and csPCa (1.0 vs 0.8, p 0.02). Among the limitations of study, we acknowledge the retrospective design and the possible under-reporting of complications.
Conclusions
MRI-targeted fusion TPBx achieves a significantly higher csPCa detection than TRBx, with a diagnostic advantage for apical and anterior lesions. No significant differences were found in terms of complications that were rare in both groups, considering a widespread adoption of antibiotic prophylaxis.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>39320521</pmid><doi>10.1007/s00345-024-05245-1</doi><orcidid>https://orcid.org/0000-0003-4681-888X</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1433-8726 |
| ispartof | World journal of urology, 2024-09, Vol.42 (1), p.535, Article 535 |
| issn | 1433-8726 0724-4983 1433-8726 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11424653 |
| source | Springer Nature |
| subjects | Aged Antibiotics Biopsy Case-Control Studies Disease prevention Humans Image-Guided Biopsy - adverse effects Image-Guided Biopsy - methods Magnetic Resonance Imaging Male Matched-Pair Analysis Medicine Medicine & Public Health Middle Aged Nephrology Oncology Perineum Postoperative Complications - epidemiology Prophylaxis Prostate - pathology Prostatic Neoplasms - pathology Rectum Reproducibility of Results Retrospective Studies Urology |
| title | Transrectal versus transperineal prostate fusion biopsy: a pair-matched analysis to evaluate accuracy and complications |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T05%3A08%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transrectal%20versus%20transperineal%20prostate%20fusion%20biopsy:%20a%20pair-matched%20analysis%20to%20evaluate%20accuracy%20and%20complications&rft.jtitle=World%20journal%20of%20urology&rft.au=Oderda,%20Marco&rft.date=2024-09-25&rft.volume=42&rft.issue=1&rft.spage=535&rft.pages=535-&rft.artnum=535&rft.issn=1433-8726&rft.eissn=1433-8726&rft_id=info:doi/10.1007/s00345-024-05245-1&rft_dat=%3Cproquest_pubme%3E3109430157%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-3e9e98c0dd413d89663b69fb061bb6c7a21f09dbe9acd975e5f185f4cf410ac53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3109526610&rft_id=info:pmid/39320521&rfr_iscdi=true |